LEADER 03363nam 2200493 450 001 9910583085103321 005 20210916153753.0 010 $a9780128144237 010 $a0128144238 010 $a9780128144244 (electronic bk.) 010 $a0128144246$b(electronic bk.) 035 $a(CKB)4100000005463973 035 $a(MiAaPQ)EBC5479170 035 $a(OCoLC)on1046633728 035 $a(PPN)243288042 035 $a(EXLCZ)994100000005463973 100 $a20180908d2018 uy 0 101 0 $aeng 135 $aurcnu|||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 00$aDosage form design considerations$hVolume I /$fedited by Rakesh K. Tekade 210 1$aLondon, United Kingdom :$cAcademic Press, an imprint of Elsevier,$d[2018] 210 4$dİ2018 215 $a1 online resource (881 pages) $cillustrations 225 1 $aAdvances in pharmaceutical product development and research series 327 $a1. Preformulation in Drug Research and Pharmaceutical product development 2. Physicochemical aspects to be considered in pharmaceutical product development 3. Role of physicochemical parameters on drug absorption and their implication in pharmaceutical product development 4. Physiologic factors related to drug absorption 5. Physicochemical, pharmaceutical, and biological considerations in GIT absorption of drugs 6. Influence of drug properties and routes of drug administration on the design of controlled release system 7. Stability and degradation studies for drug and drug product 8. First-pass metabolism considerations in pharmaceutical product development 9. Dissolution profile consideration in pharmaceutical product development 10. Drug disposition considerations in pharmaceutical product 11. Protein and tissue binging: implication on pharmacokinetic parameters 12. Preformulation studies of drug substances, protein, and Peptides: Role in drug discovery and pharmaceutical product development 13. Role of salt selection in drug discovery and development 14. Drug complexation: implications in drug solubilization and oral bioavailability enhancement 15. Solubility and solubilization approaches in pharmaceutical product development 16. Rheology and its implications on performance of liquid dosage forms 17. Micromeritics in pharmaceutical product development 18. Four stages of pharmaceutical product development: preformulation, prototype development and scale-up, biological aspects, and commercialization 19. Scale-up studies in pharmaceutical products development 20. Manipulation of physiological processes for pharmaceutical product development 21. Impact of pharmaceutical product quality on clinical efficacy 22. Formulation additives used in pharmaceutical products: emphasis on regulatory perspectives and GRAS 410 0$aAdvances in pharmaceutical product development and research series. 606 $aDrugs$xDesign 606 $aDrugs$xDosage forms 606 $aDrug development 615 0$aDrugs$xDesign. 615 0$aDrugs$xDosage forms. 615 0$aDrug development. 676 $a615.1900285 702 $aTekade$b Rakesh K. 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910583085103321 996 $aDosage form design considerations$92024621 997 $aUNINA